GPR119 agonist 2
GPR119 agonist 2 (compound 43) is an orally active GPR119 agonist. GPR119 agonist 2 shows good pharmacokinetic characteristics in rodents and can effectively improve glucose tolerance in mice and rats. GPR119 agonist 2 has the potential to study type 2 diabetes[1].
Product Specifications
CAS Number
1384951-03-4
UNSPSC
12352005
Target
GPR119
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/gpr119-agonist-2.html
Solubility
10 mM in DMSO
Smiles
CC(C)C1=NOC(N2CCC(CC2)OC3=NC=NC4=C3SC=C4C5=C(C=C(C=C5)S(=O)(C)=O)F)=N1
Molecular Formula
C23H24FN5O4S2
Molecular Weight
517.60
References & Citations
[1]Kim H, et al. Discovery of orally active sulfonylphenyl thieno [3, 2-d] pyrimidine derivatives as GPR119 agonists. Eur J Med Chem. 2023: 115584.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD27 (Tumor Necrosis Factor Receptor Superfamily 7) (rLPFS2/1611), CF647 conjugate, 0.1mg/mL
NGFB (NGF, NGFB, NGFbeta, nerve growth factor beta polypeptide) (PE)
NGFB (NGF, NGFB, NGFbeta, nerve growth factor beta polypeptide) (PE)
Alpha-2-HS-glycoprotein AHSG/HS Rabbit Polyclonal Antibody